Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Return on Equity (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Return on Equity data on record, last reported at 0.87% in Q3 2025.

  • For Q3 2025, Return on Equity fell 1.0% year-over-year to 0.87%; the TTM value through Sep 2025 reached 0.87%, down 1.0%, while the annual FY2024 figure was 0.48%, 82.0% up from the prior year.
  • Return on Equity reached 0.87% in Q3 2025 per CAPR's latest filing, down from 0.6% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.38% in Q4 2024 and bottomed at 61.91% in Q3 2023.
  • Average Return on Equity over 5 years is 4.63%, with a median of 0.87% recorded in 2025.
  • Peak YoY movement for Return on Equity: tumbled -6028bps in 2023, then soared 6105bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.61% in 2021, then tumbled by -250bps to 2.14% in 2022, then decreased by 0bps to 2.15% in 2023, then surged by 82bps to 0.38% in 2024, then tumbled by -129bps to 0.87% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.87% in Q3 2025, 0.6% in Q2 2025, and 0.4% in Q1 2025.